Model 02
Before lab time is allocated, we assess your target, application and intended use scientifically and technically. The fastest way to test assumptions — and far cheaper than a pilot that runs in the wrong direction.
How we work
The pathway is designed to de-risk your decision in the cheapest possible order. A free call establishes whether there is a fit. A feasibility scan tests the assumptions on paper before any lab time is booked. An NDA is signed before you disclose anything sensitive. Only then do we quote a pilot. If the science holds, we move to a commercial structure.
Model 01 · Start here
A focused 30-minute conversation about your pipeline, the compound or protein of interest, the application and IP considerations. No commitment. We establish together whether there is a fit and what the right next step is.
Model 03
A defined assay protocol, agreed readouts and a written technical report. Recommended for antioxidant, antiproliferative and antimicrobial screening. You receive data you can act on immediately, not a promise of future experiments.
Model 04
An 8–12 week R&D engagement with defined milestones, mechanistic data and a full deliverable package including a technical report and recommendations. For companies that need a complete scientific narrative, not just a screen result.
Model 05
A multi-month engagement: protein engineering campaigns, enzyme directed evolution, lead compound validation and mechanism-of-action studies. Regular reporting, and IP discussed from the outset. For pipeline investments that need academic-grade rigour.
Model 06
For partners where the science has proven itself and now needs a commercial structure: NDA, data room, licence terms, milestone payments, royalty models or a joint development agreement. We are open to all structures.
A free 30-minute call establishes whether there is a fit and what the right next step is. Every inquiry is acknowledged within one working day and answered by the responsible group leader within three.
